Antitumor tests of amygdalin in spontaneous animal tumor systems (1978)

Peer-Reviewed Study · C. Chester Stock, Daniel S. Martin, Kanematsu Sugiura, Ruth A. Fugmann, Isabel M. Mountain, Elisabeth Stockert, Franz A. Schmid, George S. Tarnowski · 1978

C. Chester Stock et al., 1978: The published write-up of the Sloan-Kettering laetrile mouse work, naming Sugiura's own experiments, an independent replication by Stockert, and a blind collaborative experiment with the Catholic Medical Center. It reports no significant difference in tumour growth or metastases and states that Sugiura himself regarded laetrile as palliative, not curative.

All independently conducted experiments of 3 independent observers and the carefully controlled blind experiments in which Sugiura participated have failed to confirm Sugiura's initial results.

Discussion, unpaginated web record

C. Chester Stock et al., 1978: The published write-up of the Sloan-Kettering laetrile mouse work, naming Sugiura's own experiments, an independent replication by Stockert, and a blind collaborative experiment with the Catholic Medical Center. It reports no significant difference in tumour growth or metastases and states that Sugiura himself regarded laetrile as palliative, not curative. Funder: not stated in the text retrieved; the work was done at the Sloan-Kettering Institute with amygdalin supplied as 'amygdalin MF', a sample prepared in Mexico for the McNaughton Foundation, and characterized with FDA help. Maker: McNaughton Foundation (laetrile movement) supplied the drug sample. Comparator: saline-treated controls, including a blinded allocation. Conflicts: none declared in the retrieved text. The paper records Sugiura's dissent in his own words: 'Sugiura continues to believe that laetrile is not a curative but is a palliative agent.' Study type: animal.